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Objectives: To report changes in perceived visual func-
tioning after surgery for symptomatic cataract with pre-
operative corrected distance visual acuity [CDVA] of 0.4
logMAR or better (Snellen equivalent, 20/50) and to in-
vestigate the relationship between any observed changes
and preoperative physical characteristics and psycho-
physical consequences of the lens opacity and any changes
in psychophysical findings after the procedure.
Methods: Eighty-five patients with cataract completed
a validated questionnaire concerning functional vision
satisfaction and a series of visual performance assess-
ments before and 2 months after cataract surgery. The
lens optical density and Lens Opacities Classification Sys-
tem III score of the cataract were recorded. Correlations
between changes in the Rasch-analyzed questionnaire
score and changes in visual performance after cataract
surgery, as well as preoperative psychophysical mea-
sures, lens optical density, and Lens Opacities Classifi-
cation System III score, were determined.
Results: The mean (SD) questionnaire score improved
from 2.15 (0.36) to 1.54 (0.41) (P .001). The preop-
erative questionnaire score (r=−0.44), preoperative me-
sopic glare disability [GD] (at 1.5 cycles per degree [cpd]
[r=0.34] and 3.0 cpd [r=0.27]), and preoperative phot-
opic GD (at 1.5 cpd [r=0.24] and 3.0 cpd [r=0.30])
showed statistically significant correlations with per-
ceived improvements in visual functioning after sur-
gery (P .05). Changes in perceived visual functioning
correlated significantly with changes in mesopic GD (at
1.5 cpd [r=−0.43] and 3.0 cpd [r=−0.28]; P .05) and
photopic GD (at 1.5 cpd [r=−0.24] and 3.0 cpd [r=−0.39];
P .05). Neither preoperative CDVA nor change in CDVA
after surgery correlated significantly with perceived im-
provement in visual functioning after the procedure
(P .05 for both).
Conclusion: Psychophysical tests alternative to CDVA
better represent improvements in self-reported visual func-
tioning following removal of symptomatic nonad-
vanced cataract.
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A GE-RELATED CATARACT ISone of the most commoneye pathologies in theWestern world,1-4 and theunprecedented increase in
life expectancy5 is leading to a dramatic rise
in the demand for cataract surgery.1-3,6 To
judge the holistic impact of modern cata-
ract surgery on the life of patients under-
going this procedure—and thus its appro-
priateness—it is necessary to identify and
quantify the preoperative visual loss and
any benefits perceived by the patient.
The 2 most widely used methods for
evaluating appropriateness for and ben-
efits of cataract surgery include the mea-
surement of corrected distance visual acu-
ity (CDVA) and case history evaluation of
patient-reported symptoms.7-13 Visual acu-
ity (VA) thresholds for treatment in cata-
ract surgery have decreased dramatically
in the past 15 years.14-16 It has recently been
suggested that a minimum of 1 line of im-
provement on the logMAR chart in cases
in which the preoperative VA is 0.4 log-
MAR (Snellen equivalent, 20/50) and a
minimum of half a line of improvement
in cases in which the preoperative VA is
0.2 logMAR (20/32) are required for a ben-
efit to be perceived by the patient.7,17
However, it has also been suggested that
VAisrelativelyunaffectedbycataractandmay
notbethemostappropriatetoolfortheevalu-
ation of visual functioning in patients with
cataract.18-23Complementarytechniquesthat
havebeeninvestigated includecontrast sen-
sitivity (CS),22 glare disability (GD),24 read-
ing performance,25 and visual functioning
assessed by a questionnaire.12,26,27 Morpho-
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logical28,29 and optical30-33 characteristics of lens opacifica-
tion have also been used in the assessment of cataract and
have the advantage of being somewhat independent of pa-
tient cooperation and ocular comorbidity.
The study reported herein used patient self-reported vi-
sual functioning (responses to a validated questionnaire)
and a number of psychophysical methods for assessing vi-
sual performance in patients with symptomatic cataract
and CDVA of 0.4 logMAR or better (Snellen equivalent,
20/50) before and after cataract surgery. The purposes
of this study were to (1) investigate changes in subjective
and self-reported visual functioning in patients undergo-
ing surgery for symptomatic cataract who had high-
contrast CDVA of 0.4 logMAR or better (20/50), (2) de-
termine whether alternative psychophysical outcome
measures are more appropriate than CDVA in reflecting
any observed changes in visual functioning after surgery,
and (3) investigate whether preoperative psychophysi-
cal, lens optical, or lens morphological measures are of
prognostic value for surgical intervention in such cases.
In addition, we conducted a survey of all consultant
ophthalmologists in the United Kingdom and the Re-
public of Ireland to report on the preoperative testing of
visual function currently used before cataract surgery.
METHODS
PATIENTS
Eighty-five consecutive patients with nonadvanced cataract and
no other ocular pathology who were scheduled to undergo phaco-
emulsification cataract extraction and implantation with an in-
traocular lens (Tecnis 1-Piece intraocular lens; Advanced Medi-
cal Optics, Inc, Santa Ana, California) were recruited from
ophthalmic clinics at the Institute of Eye Surgery, Whitfield Clinic,
Waterford, Ireland. Nonadvanced cataract was defined as a cata-
ract for which CDVA was 0.4 logMAR or better (Snellen equiva-
lent, 20/50). Only 1 eye of each patient (the one with the worse
CDVA) was recruited. Previous contralateral cataract surgery was
not an exclusion criterion. The fellow eyes of 65 of the 82 study
eyes were phakic, whereas 17 were pseudophakic. Ethics com-
mittee approval was granted from the local regional ethics com-
mittee (Research Ethics Committee, Health Service Executive,
South Eastern Area, Ireland), and the research was conducted in
accordance with the principles of the Declaration of Helsinki.
Exclusion criteria were having CDVA worse than 0.4 log-
MAR, any preoperative ocular comorbidity (whether visually
consequential or inconsequential), a history of ocular trauma,
a history of diabetes mellitus, and any previous intraocular sur-
gery in the proposed study eye.
Data were collected on 2 separate occasions: 1 to 4 weeks
(mean [SD], 17 [16] days) before planned cataract surgery and
2 months (61 [16] days) after surgery.
SUBJECTIVE VISUAL FUNCTIONING
Subjectively perceived visual functioning in everyday life was
evaluated using the Priquest questionnaire, which is part of the
Nationell Indikationsmodell fo¨r Kataraktextraktion (NIKE) in-
dication tool, a validated indication tool for cataract surgery
used in Sweden since 2006.12 Rasch analysis was applied to the
questionnaire data using commercial software (WINSTEPS
Rasch measurement computer program, version 3.70.0.2;
Beaverton, Oregon [http://www.Winsteps.com]), thus calibrat-
ing item difficulty and patient ability on the same scale.34,35 We
found a significant gain in precision after Rasch scaling of the
questionnaire (a gain of 32% and a relative precision of 1.32),
thus reinforcing the current evidence with respect to the ben-
efits of subjecting questionnaires to Rasch scaling.27,36,37
VISUAL PERFORMANCE TESTING
Corrected distance visual acuity was measured monocularly and
withthepatient’sbestsubjectiverefractionusingthelogMARchart
providedbyaletterchart(TestChart2000PRO;ThomsonSoftware
Solutions, Hertfordshire, England) at a testing distance of 4 m.
Contrast sensitivity was measured using the letter chart and
the sine wave grating-based Functional Acuity Contrast Test (Op-
tec 6500 Vision Tester; Stereo Optical Co, Inc, Chicago, Illinois).
Best-corrected letterCSwasdeterminedusingETDRS(EarlyTreat-
ment Diabetic Retinopathy Study) letters in logMAR form
(monocularly with the study eye) at a distance of 4 m. The letters
were shown in isolated rows, one row at a time, and the contrast
of letters of predetermined size (and therefore a predetermined
setofprimaryspatial frequencies)wasreducedsystematicallyusing
thesoftware’scontrast-adjustment function(calibratedbeforecom-
mencement of the study) until the patient’s contrast threshold
was reached (ie, the patient could read no more letters). Contrast
sensitivity was also determined using the Functional Acuity Con-
trast Test device according to a protocol previously described.38
Testing was performed under mesopic (3 candela per square me-
ter [cd/m2]) and photopic (85 cd/m2) conditions.
The Functional Acuity Contrast Test was repeated in a man-
ner similar to that of the CS test under mesopic and photopic
conditions but with additional glare light (1 lux for mesopic
and 10 lux for photopic glare testing) to assess GD.
Reading speed and near VA (logRAD [log reading acuity])
were measured with an English version of the standardized Rad-
ner reading charts while adhering to a previously described pro-
tocol.39 Stereoacuity was measured using the TNO stereo test
(Lameris Instrumenten, Utrecht, the Netherlands). Retino-
topic ocular sensitivity was measured by microperimetry (Mi-
croperimeter MP 1; Nidek Technologies Srl, Albignasego, Italy)
while adhering to a previously described protocol.40 Retino-
topic ocular sensitivity was calculated for 4 areas: fixation (1
stimulus), within the central 5° of fixation (average of 5 stimuli),
between 5° and 10° of fixation (average of 8 stimuli), and within
the central 10° of fixation (average of 13 stimuli).
LENS ASSESSMENT AND CATARACT SURGERY
Lens optical density was measured using Scheimpflug images
taken by an eye scanner (Pentacam Comprehensive Eye Scan-
ner, software version 1.16; Oculus, Inc, Wetzlar, Germany) while
adhering to a previously described protocol.31 The “densitom-
etry along a line” part of the software was used to analyze the
images, and a mean lens optical density value was recorded di-
rectly from the visual axis line appearing in the Scheimpflug
image. Cataracts were categorized and graded clinically at the
slitlamp in terms of nuclear, cortical, and posterior subcapsu-
lar cataract by a single ophthalmologist (S.B.) using the Lens
Opacities Classification System III.28
Phacoemulsification cataract surgery and intraocular lens im-
plantation in the capsular bag were performed by a single sur-
geon (S.B.) using topical anesthesia and a standard technique.
SURVEY
A postal survey was sent to all consultant ophthalmologists listed
in the databases of the Royal College of Ophthalmologists in the
United Kingdom and of the Irish College of Ophthalmologists in
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theRepublicof Irelandtoascertainthemethodsother thanVAcur-
rently used in the preoperative assessment of patients with cata-
ract. The mailing comprised an anonymous questionnaire with a
stamped, addressed envelope for return of the completed survey.
STATISTICAL ANALYSIS
The sample size was determined by power analysis: thus, a sample
of 82 individuals would have power in excess of 80% to detect a
correlation of 0.30 at the 5% level of significance. Descriptive sta-
tistics were calculated for all measured variables, including demo-
graphic, ocular, refractive, psychophysical, cataract optical, and
cataract morphological data, as well as data on subjective visual
functioning (the questionnaire) and the survey responses. Vi-
sual acuity rating scores41 were used for the statistical analysis of
VA data. Statistical analysis was performed using the PASW Sta-
tistics 18.0 software package (IBM Corp, Somers, NY).
Preoperative and postoperative measures were compared
using the paired-samples t test (for continuous variables: Rasch-
scaled score, CDVA, spherical equivalent, CS, GS, logRAD, read-
ing speed, and retinal sensitivity) or the Wilcoxon 2-related-
samples signed ranks test (for stereopsis, the categorical variable).
The independent-samples t test was used to compare Rasch-
scaled scores in VA subgroups (subgroups based on having pre-
operative CDVA of 0.2 or 0.2 logMAR and also based on
having preoperative CDVA of 0 or 0 logMAR).
Correlations between observed changes in Rasch-scaled
scores and observed changes in psychophysical measures af-
ter cataract surgery, as well as correlations between observed
changes in Rasch-scaled scores and preoperative psychophysi-
cal measures (lens optical density and Lens Opacities Classi-
fication System III scores), were investigated using Spearman
rank correlations. Tests were 2-sided in all analyses, and P .05
was considered statistically significant.
RESULTS
Eighty-five patients (85 eyes) met the inclusion criteria
and were recruited into this study. Two patients devel-
oped transient corneal edema, and 1 patient developed
self-limiting cystoid macular edema. Their data were there-
fore excluded from analysis, thus yielding data from 82
eyes of 82 patients for analysis.
The mean (SD) age was 66.8 (8.8) years (range, 47-85
years). The male to female ratio was 28:54, and the right
eye to left eye ratio was 39:43. The mean (SD) time from
preoperativeassessmenttosurgerywas17(16)days(range,
1-90 days), and the mean (SD) follow-up was 61 (16) days
(range, 15-120 days).
Themean(SD)Rasch-scaledquestionnairescoreimproved
from 2.15 (0.36) (range, 1.37-3.13) to 1.54 (0.41) (range,
1.00-2.61; P .001). All psychophysical measures tested,
with theexceptionofCDVAof the felloweye,exhibitedsta-
tistically significant improvementsafter surgery (Table1).
The following preoperative (baseline) psychophysical
variables showed statistically significant correlations with
observed changes in the Rasch-scaled questionnaire score
after cataract surgery: CS by letters at 1.2 and 2.4 cycles
per degree (cpd), mesopic CS by gratings at 1.5 cpd, me-
sopic GD at 1.5 and 3.0 cpd, and photopic GD by gratings
at 1.5 and 3.0 cpd (Table2). The remaining variables were
not significantly correlated (P .05 for all). There was no
significantdifferencebetweenpreoperative (baseline)CDVA
subgroups in terms of observed changes in Rasch-scaled
questionnaire score after cataract surgery (Figure1). The
relationship between the preoperative Rasch-scaled ques-
tionnaire score and observed changes in the Rasch-scaled
questionnaire score after cataract surgery is represented by
a scatterplot (Figure2), and the correlation between these
variables was statistically significant (r=−0.44; P .001).
Changes in the following psychophysical variables af-
ter cataract surgery showed statistically significant cor-
relations with changes in the Rasch-scaled question-
naire score: CS by letters at 1.2, 2.4, and 24.0 cpd; mesopic
GD at 1.5 and 3.0 cpd; photopic GD at 1.5, 3.0, and 6.0
cpd; reading acuity; and reading speed at a print size of
0.5 logRAD and at print sizes between 0.8 and 1.2 logRAD
(Table 3). Changes in the remaining variables were not
significantly correlated with changes in the Rasch-
scaled questionnaire score (P .05 for all).
SURVEY
The survey was mailed to all 972 members of the Royal
College of Ophthalmologists and all 66 members of the
Irish College of Ophthalmologists, with a 56.1% re-
sponse rate (582 responses). Of the respondents, 38
(6.5%) did not perform cataract surgery, thus yielding
544 responses for analysis. Routinely used methods of
preoperative visual function assessment and cataract mor-
phological assessment are illustrated in Figure3. In brief,
100.0% of consultant ophthalmic surgeons use VA (90.8%
use Snellen, 9.1% use logMAR, and 9.1% use both Snel-
len and logMAR) in the preoperative assessment of vi-
sual function before cataract surgery, whereas 2.6% use
a validated questionnaire and 2.2% test CS and/or GD.
COMMENT
Toourknowledge, this studyrepresents the first evaluation
of prognostic indicators and outcome measures for surgi-
cal removal of symptomatic nonadvanced cataract in a way
that relates topatients’ subjectivelyperceived improvement
invisual functioningafter theprocedure.Wereport thatpa-
tients’ self-reported impairmentofvisual functioningattrib-
utable tocataractwithCDVAof0.4 logMARorbetter (Snel-
lenequivalent,20/50)wasalleviatedbysurgery.Ourresults
areconsistentwithprevious studies investigating improve-
ment in visual functioning after cataract surgery18,36,43 and
are consistent with guidelines published by the American
Academy of Ophthalmology (http://one.aao.org/CE
/PracticeGuidelines/PPP_Content.aspx?cid=a80a87ce
-9042-4677-85d7-4b876deed276#section4). However, our
results are not in keeping with the recommendations of
some investigators,7,11,17 who have stated that the thresh-
old for cataract surgery should be based on preoperative
CDVA of 0.3 logMAR (Snellen equivalent, 20/40) for the
better eye and 0.52 logMAR (20/62) for the worse eye and
who contend that success should be defined as at least 2
lines of gain in logMAR CDVA. Nevertheless, the authors
of one of these studies11 did concede that the ethical con-
siderations of setting such preoperative VA limits for cata-
ract surgery are open to criticism and that visual symp-
toms reported by the patient should represent an indication
for operating in patients with good CDVA.
ARCH OPHTHALMOL / VOL 129 (NO. 9), SEP 2011 WWW.ARCHOPHTHALMOL.COM
1157
©2011 American Medical Association. All rights reserved.
Downloaded From: http://jamanetwork.com/ by a Flinders University of South Australia User  on 12/19/2016
In this study, all psychophysical measures tested, with
the exception of CDVA of the fellow eye, showed statisti-
cally significant improvements after surgery. All these sta-
tistically significant changes are of limited or indetermi-
nate clinical value unless associated with improvement in
subjectively perceived visual functioning after the proce-
Table 1. Changes in Psychophysical Measures After Cataract Surgery in 82 Patients
Variable
Mean (SD)
P ValuePreoperative Postoperative
High-contrast VA, logMAR
CDVA in study eye 0.18 (0.16) 0.02 (0.10) .001
CDVA in fellow eye 0.12 (0.12) 0.10 (0.14) .10
Refractive status: SE in study eye, D 0.10 (2.80) −0.31 (0.62) .20
Photopic logCS by letters according to spatial frequency, cpd
1.2 (n = 79) 1.38 (0.19) 1.70 (0.26) .001
2.4 (n = 79) 1.31 (0.25) 1.63 (0.24) .001
6.0 (n = 78) 1.00 (0.31) 1.43 (0.20) .001
9.6 (n = 72) 0.78 (0.29) 1.23 (0.22) .001
15.2 (n = 53) 0.54 (0.27) 1.00 (0.21) .001
24.0 (n = 13) 0.34 (0.14) 0.59 (0.31) .03
Mesopic logCS by gratings according to spatial frequency, cpd
1.5 (n = 79) 1.44 (0.22) 1.83 (0.16) .001
3.0 (n = 77) 1.51 (0.24) 1.93 (0.19) .001
6.0 (n = 40)a 1.31 (0.20) 1.63 (0.25) .001
12.0 (n = 2)a 1.11 (0.10) 1.11 (0.10) .001
18.0 (n = 1)a 0.60 (. . .) 0.90 (. . .) . . .
Photopic logCS by gratings according to spatial frequency, cpd
1.5 (n = 79) 1.35 (0.20) 1.71 (0.16) .001
3.0 (n = 79) 1.58 (0.22) 1.97 (014) .001
6.0 (n = 57) 1.46 (0.21) 1.90 (0.21) .001
12.0 (n = 24)a 1.16 (0.17) 1.48 (0.21) .001
18.0 (n = 19)a 0.95 (0.20) 1.19 (0.27) .001
Mesopic logGD by gratings according to spatial frequency, cpd
1.5 (n = 64) 1.31 (0.23) 1.61 (0.24) .001
3.0 (n = 61) 1.45 (0.22) 1.78 (0.21) .001
6.0 (n = 22)a 1.36 (0.25) 1.58 (0.17) .02
12.0 (n = 1)a 0.09 (. . .) 0.09 (. . .) . . .
18.0 (n = 1)a 0.78 (. . .) 0.78 (. . .) . . .
Photopic logGD by gratings according to spatial frequency, cpd
1.5 (n = 74) 1.34 (0.20) 1.62 (0.18) .001
3.0 (n = 71) 1.57 (0.20) 1.91 (0.18) .001
6.0 (n = 47) 1.47 (0.22) 1.84 (0.23) .001
12.0 (n = 22)a 1.14 (0.15) 1.49 (0.24) .001
18.0 (n = 13a) 1.01 (0.21) 1.19 (0.30) .05
Reading performance
logRAD (n = 80) 0.33 (0.21) 0.19 (0.09) .001
logRAD score (n = 80) 0.33 (0.21) 0.20 (0.09) .001
Reading speed, wpm, by print size, logRAD
1.2 (n = 80) 150 (31) 170 (31) .001
1.1 (n = 80) 144 (31) 162 (30) .001
0.9 (n = 77) 149 (37) 169 (32) .001
0.8 (n = 77) 149 (36) 164 (30) .001
0.7 (n = 77) 143 (37) 166 (32) .001
0.6 (n = 72) 138 (39) 162 (37) .001
0.5 (n = 71) 136 (49) 157 (40) .001
0.4 (n = 68) 130 (42) 156 (42) .001
0.3 (n = 64) 97 (55) 142 (43) .001
0.2 (n = 31) 101 (41) 129 (50) .01
0.1 (n = 2) 110 (16) 137 (22) .10
Retinotopic ocular sensitivity, dB
Fixation (n = 81) 14.6 (5.0) 17.4 (3.4) .001
Central 5° (n = 81) 15.9 (3.8) 18.6 (1.9) .001
Between 5° and 10° (n = 81) 16.5 (3.5) 18.8 (2.0) .001
Central 10° (n = 81) 16.3 (3.6) 18.7 (1.9) .001
Stereopsis, median, mode, min of arc (n = 80) 120, 120 120, 60 .001
Abbreviations: CDVA, corrected distance visual acuity; cpd, cycles per degree; CS, contrast sensitivity; D, diopters; ellipses, not applicable; GD, glare disability;
logRAD, log reading acuity; SE, spherical equivalent; VA, visual acuity; wpm, words per minute.
aOnly a small number of patients achieved the minimum score during CS and GD testing by gratings. This is owing to a known floor effect when testing CS/GD
with the Functional Acuity Contrast Test, in the presence of cataract.42
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dure. We found that improvement in the Rasch-scaled ques-
tionnaire score correlated significantly with improvement
in CS and GD at particular spatial frequencies. In addi-
tion, and of prognostic value, we found significant corre-
lations between improvement in the questionnaire score
and preoperative (baseline) GD at the same spatial fre-
quencies. This latter finding indicates that GD not only is
a useful outcome measure for cataract surgery but also may
be a valuable prognostic indicator for improvement in vi-
sual functioning attributable to the lens opacity after suc-
cessful surgery. We believe these findings are consistent
with the clinical experience of many ophthalmic surgeons
who see patients reporting decreased visual functioning de-
Table 2. Significant Correlations Between Preoperative
(Baseline) Psychophysical Variables and Postoperative
Changes in Rasch-Scaled Questionnaire Score
Preoperative Psychophysical Variable
Spearman Correlation
With Postoperative
Changes in
Rasch-Scaled
Questionnaire Score
Contrast sensitivity
Photopic by letters according to spatial
frequency, cpd
1.2 (n = 79) −0.27a
2.4 (n = 79) −0.30a
Mesopic by gratings according to spatial
frequency, cpd
1.5 (n = 79) 0.22a
Glare disability
Mesopic by gratings according to spatial
frequency, cpd
1.5 (n = 64) 0.34b
3.0 (n = 61) 0.27a
Photopic by gratings according to spatial
frequency, cpd
1.5 (n = 4) 0.24a
3.0 (n = 71) 0.30b
Abbreviation: cpd, cycles per degree.
aCorrelation is significant at the .05 level (2-tailed).
bCorrelation is significant at the .01 level (2-tailed).
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Figure 1. Change in Rasch-scaled questionnaire scores of patients in various
preoperative (baseline) corrected distance visual acuity (CDVA) subgroups.
A, Change in questionnaire scores of patients with preoperative CDVA of 0.2
logMAR or better (Snellen equivalent, 20/32; 46 patients) vs patients with
preoperative CDVA of less than 0.2 logMAR (20/32; 36 patients; P=.93,
paired t test). B, Change in questionnaire scores of patients with preoperative
CDVA of 0.0 logMAR or better (Snellen equivalent, 20/20; 9 patients) vs
patients with preoperative CDVA of less than 0.0 logMAR (20/20; 73 patients;
P=.965, paired t test). Each box is given by the 75% percentile (top) and
25% percentile (bottom) and its length (interquartile range) by the difference
between the 2 percentiles. The horizontal line inside the box represents the
median (50% percentile). The whiskers represent 95% confidence intervals.
The open circles represent outliers outside the 95% confidence intervals.
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Figure 2. Preoperative (baseline) Rasch-scaled questionnaire score vs
change in Rasch-scaled questionnaire score.
Table 3. Significant Correlations Between Postoperative
Changes in Psychophysical Variables and Postoperative
Changes in Rasch-Scaled Questionnaire Score
Psychophysical Variable
(Postoperative Change)
Spearman Correlation
With Postoperative
Changes in
Rasch-Scaled
Questionnaire Score
Contrast sensitivity
Photopic by letters according to spatial
frequency, cpd
1.2 (n = 79) −0.32a
2.4 (n = 79) −0.28b
24.0 (n = 13) −0.48b
Glare disability
Mesopic by gratings according to spatial
frequency, cpd
1.5 (n = 64) −0.43a
3.0 (n = 61) −0.28b
Photopic by gratings according to spatial
frequency, cpd
1.5 (n = 74) −0.24b
3.0 (n = 71) −0.39b
6.0 (n = 47) −0.35b
Reading performance
logRAD 0.26b
Reading speed, wpm, by print size
1.2 (n = 80) −0.32a
1.1 (n = 80) −0.29a
0.9 (n = 77) −0.35a
0.8 (n = 77) −0.22b
0.5 (n = 71) −0.28b
Abbreviations: cpd, cycles per degree; logRAD, log reading acuity;
wpm, words per minute.
aCorrelation is significant at the .01 level (2-tailed).
bCorrelation is significant at the .05 level (2-tailed).
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spite good high-contrast CDVA preoperatively. It is likely
that these patients are reporting the symptoms of loss of
CS, which is further provoked under conditions of glare,
leading to GD, which is known to be associated with deg-
radation of the retinal image as a result of intraocular stray
light arising at the lens opacity.33 Our findings are consis-
tent with those of previous investigators18,19,21,22,24 with re-
spect to GD and cataract and with regard to alleviation of
GD after surgical removal of the lens opacity.
Improvement invisual functioningaftercataract surgery
wasrelatedtothepreoperativequestionnairescore(Figure2);
a high preoperative score was associated with the greatest
improvement in visual functioning, although this finding
should be interpreted with some degree of caution because
the preoperative score is part of both variables. Neverthe-
less, this findingsuggestsa role for formalassessmentofpa-
tients’ subjectivevisual functioning in thepreoperative set-
ting. We make this suggestion, mindful that only 2.6% of
consultantophthalmicsurgeonsintheUnitedKingdomand
Republicof Irelandroutinelyuseaquestionnaire in thepre-
operative evaluation of patients with cataract. This finding
alsohasimportantmedicolegalimplicationsrelatingtodocu-
mentationofvisualperformanceandvisual functioningbe-
fore cataract surgery.44 If we fail to measure and document
variables that relate to the improvementof subjectivelyper-
ceivedvisual functioningaftercataractsurgeryandcontinue
tomeasureCDVAonly,wewill beunable todrawondocu-
mentation demonstrating that the patient had subjectively
perceived impairment of visual functioning and that he or
she was likely to benefit from surgery.
Therefore, we believe that there is a rationale to support
the incorporationofGDtestingundermesopicand/orphot-
opicconditions(at1.5and/or3.0cpd),aswell asevaluation
of functional vision by means of a validated questionnaire,
into the preoperative assessment of patients with sympto-
maticnonadvancedcataract.These supplemental tests rep-
resent only a 5- to 10-minute extension of a typical preop-
erativeassessmentforcataractsurgery,dependingonwhether
the questionnaire is completed before that consultation.
We report no significant correlation between preopera-
tive (baseline) VA and improvement in visual functioning
and no statistically significant correlation between the ob-
served improvement in CDVA and the observed improve-
ment in self-reported visual functioning. Furthermore, we
found that the subgroup of patients with preoperative CDVA
of 0.0 logMAR or better (Snellen equivalent, 20/20) in
the study eye did not differ significantly from the sub-
group of patients with preoperative CDVA of less than 0.0
logMAR (20/20) in terms of change in perceived visual
functioning.Asimilar finding is reportedwhenpatientswere
dichotomized according to preoperative CDVA of 0.2 or
better vs less than 0.2 logMAR (20/32), indicating that pre-
operative CDVA in this group of patients is of no prognos-
tic value in discriminating between those who are and are
not likely to experience improvement in visual function-
ing after the procedure. These findings are clinically im-
portant given that CDVA is the only psychophysical test
used by most consultant ophthalmic surgeons and sug-
gest that VA used in isolation is not the most appropriate
test for assessing symptomatic nonadvanced cataract.
Visual acuity is a measure of the spatial resolving abil-
ity of the visual system under conditions of very high con-
trast. In terms of CS, VA is defined as a measure of the
highest spatial frequency that can be detected at 100%
contrast.45 However, CDVA alone fails to capture the func-
tional problems attributable to cataract because it mea-
sures only one aspect of visual impairment. Most indi-
viduals engage in few daily activities that involve visual
stimuli at 100% contrast, reflected in the consensus that
CS is a stronger correlate of visual function.22
In conclusion, this study shows that the strongest pre-
operative indicators for improvement in visual function-
ing after surgery for symptomatic nonadvanced cataract are
GD (tested at low and medium spatial frequencies) and
questionnaire score. Neither preoperative CDVA nor change
in CDVA after the procedure relates to the observed im-
provement in visual functioning. These findings suggest
that ophthalmologists should not select patients with symp-
tomatic nonadvanced cataract for surgery on the basis of
CDVA alone but rather should consider introducing GD
testing at low and medium spatial frequencies and admin-
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Figure 3. The relative popularity of methods used by consultant ophthalmic
surgeons in the United Kingdom and the Republic of Ireland for evaluating
patients before cataract surgery. A, Methods of assessment of visual function
in patients being considered for cataract surgery before the procedure.
B, Methods of preoperative assessment of morphological and optical
characteristics of lens opacification in patients being considered for cataract
surgery before the procedure. CS indicates contrast sensitivity; GD, glare
disability; LOCS III, Lens Opacities Classification System III; LOD, lens optical
density; RAPD, relative afferent pupillary defect; and VA, visual acuity.
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istration of a validated visual functioning questionnaire into
the decision-making process. These tests are simple to ad-
minister, consume very little time, and can easily be incor-
porated into a busy ophthalmic practice.
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